HHS Announces $100 Million STREETS Program for Addiction Recovery and Homelessness

Federal Investment Targets Addiction Crisis Through Digital Health Expansion

The U.S. Department of Health and Human Services announced a $100 million federal investment to combat addiction and homelessness through its new Safety Through Recovery, Engagement and Evidence-based Treatment and Supports program. The initiative, announced on February 2, 2026, represents a significant commitment to expanding treatment capacity while leveraging digital health technologies to reach underserved populations.

HHS Secretary Robert F. Kennedy Jr. positioned the program as part of the broader Great American Recovery Initiative, emphasizing coordination between federal agencies, healthcare providers, and community organizations. The program will initially operate in eight communities before expanding through partnerships with local governments and community groups.

Operational Framework and Financial Structure

The STREETS program establishes an outcomes-based funding model requiring participating organizations to demonstrate measurable results to receive and maintain federal support. The initiative provides targeted outreach, psychiatric care, medical stabilization, and crisis intervention services specifically for individuals experiencing both homelessness and substance use disorders.

Healthcare organizations can anticipate new revenue opportunities through this federal funding stream, though success requires robust data collection and reporting capabilities to meet performance metrics. The program also opens participation to faith-based organizations, potentially expanding the provider network beyond traditional healthcare entities.

Telehealth Takes Center Stage in Treatment Delivery

Digital health tools have emerged as critical components in substance use disorder treatment, particularly since the COVID-19 pandemic transformed care delivery models. Virtual platforms now support screening, therapy, and medication-assisted treatment while enabling patients to maintain continuity of care from home.

Healthcare organizations must navigate current regulatory uncertainties surrounding telehealth prescribing authority. The DEA’s temporary waiver allowing controlled substance prescriptions without initial in-person visits expires December 31, 2026. Any policy changes could significantly impact medication-assisted treatment programs delivered through digital channels.

Regulatory and Financial Considerations for Healthcare Organizations

The initiative includes expanded federal matching funds for medication-assisted treatment, with states and tribes now eligible for 50 percent federal reimbursement when providing buprenorphine, methadone, and naltrexone to parents whose children face foster care placement risk.

Healthcare finance teams should prepare for potential shifts in reimbursement structures as federal policy emphasizes outcome-driven care models. Organizations offering substance use disorder services through telehealth platforms need contingency planning for possible DEA rule changes that could affect prescribing protocols and revenue streams.

The administration’s focus on digital health integration aligns with broader healthcare transformation trends, suggesting continued federal support for technology-enabled care delivery models. Healthcare organizations positioned to demonstrate clinical outcomes and cost effectiveness through digital platforms may find competitive advantages in securing future federal contracts.

Healthcare organizations navigating addiction treatment funding and regulatory changes can benefit from specialized guidance. Contact James Moore’s healthcare practice team to discuss how these developments may impact your organization.

All content provided in this article is for informational purposes only. Matters discussed in this article are subject to change. For up-to-date information on this subject please contact a James Moore professional. James Moore will not be held responsible for any claim, loss, damage or inconvenience caused as a result of any information within these pages or any information accessed through this site.